Replication-competent retrovirus vector-mediated prodrug activator gene therapy in experimental models of human malignant mesothelioma

Replication-competent retrovirus (RCR) vectors have been shown to achieve significantly enhanced tumor transduction efficiency and therapeutic efficacy in various cancer models. In the present study, we investigated RCR vector-mediated prodrug activator gene therapy for the treatment of malignant me...

Descripción completa

Detalles Bibliográficos
Autores principales: Kawasaki, Yoshiko, Tamamoto, Atsuko, Maeyama, Yoshihiro, Yamaoka, Norie, Terada, Nobuyuki, Okamura, Haruki, Kasahara, Noriyuki, Kubo, Shuji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2011
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3159547/
https://www.ncbi.nlm.nih.gov/pubmed/21660062
http://dx.doi.org/10.1038/cgt.2011.25

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3159547/
https://www.ncbi.nlm.nih.gov/pubmed/21660062
http://dx.doi.org/10.1038/cgt.2011.25

Ejemplares similares